> top > docs > PMC:7228307 > spans > 48411-48625 > annotations

PMC:7228307 / 48411-48625 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
945 107-111 Gene denotes HER2 Gene:13866
946 178-182 Gene denotes HER2 Gene:13866
948 209-213 Species denotes mice Tax:10090
951 48-59 Chemical denotes trastuzumab MESH:D000068878
952 65-77 Chemical denotes margetuximab MESH:C000617981
954 194-199 Disease denotes tumor MESH:D009369

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T391 113-118 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T90 94-98 Disease denotes ADCC http://purl.obolibrary.org/obo/MONDO_0008734
T91 194-199 Disease denotes tumor http://purl.obolibrary.org/obo/MONDO_0005070

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T832 113-127 http://purl.obolibrary.org/obo/CL_0001034 denotes cells in vitro

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T224 113-118 http://purl.obolibrary.org/obo/CL_0000000 denotes cells

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
945 107-111 Gene denotes HER2 Gene:13866
946 178-182 Gene denotes HER2 Gene:13866
948 209-213 Species denotes mice Tax:10090
951 48-59 Chemical denotes trastuzumab MESH:D000068878
952 65-77 Chemical denotes margetuximab MESH:C000617981
954 194-199 Disease denotes tumor MESH:D009369

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T46 209-213 Species denotes mice NCBItxid:10095|NCBItxid:10088

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T279 0-214 Sentence denotes This was apparent when compared with unmodified trastuzumab the  margetuximab showed enhanced ADCC against HER2+ cells in vitro and demonstrated superior antitumor effects in an HER2‐expressing tumor model in mice.

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T390 113-118 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646

LitCovid-sample-PD-GO-BP-0

Id Subject Object Predicate Lexical cue
T114 94-98 http://purl.obolibrary.org/obo/GO_0001788 denotes ADCC

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T39 194-199 Disease denotes tumor http://purl.obolibrary.org/obo/MONDO_0005070

LitCovid-sample-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T35 194-199 Phenotype denotes tumor http://purl.obolibrary.org/obo/HP_0002664

LitCovid-sample-GO-BP

Id Subject Object Predicate Lexical cue
T114 94-98 http://purl.obolibrary.org/obo/GO_0001788 denotes ADCC

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T114 94-98 http://purl.obolibrary.org/obo/GO_0001788 denotes ADCC

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T279 0-214 Sentence denotes This was apparent when compared with unmodified trastuzumab the  margetuximab showed enhanced ADCC against HER2+ cells in vitro and demonstrated superior antitumor effects in an HER2‐expressing tumor model in mice.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T35 194-199 Phenotype denotes tumor http://purl.obolibrary.org/obo/HP_0002664